HEADER HYDROLASE 03-FEB-18 6FNE TITLE STRUCTURE OF HUMAN BRAG2 (SEC7-PH DOMAINS) WITH THE INHIBITOR BRAGSIN TITLE 2 BOUND TO THE PH DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: IQ MOTIF AND SEC7 DOMAIN-CONTAINING PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADP-RIBOSYLATION FACTORS GUANINE NUCLEOTIDE-EXCHANGE PROTEIN COMPND 5 100,ADP-RIBOSYLATION FACTORS GUANINE NUCLEOTIDE-EXCHANGE PROTEIN 2, COMPND 6 BREFELDIN-RESISTANT ARF-GEF 2 PROTEIN,BRAG2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IQSEC1, ARFGEP100, BRAG2, KIAA0763; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ARF GEF, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.NAWROTEK,M.ZEGHOUF,J.CHERFILS REVDAT 4 17-JAN-24 6FNE 1 REMARK REVDAT 3 25-NOV-20 6FNE 1 TITLE REMARK REVDAT 2 03-APR-19 6FNE 1 JRNL REVDAT 1 13-MAR-19 6FNE 0 JRNL AUTH A.NAWROTEK,S.BENABDI,S.NIYOMCHON,M.H.KRYSZKE,C.GINESTIER, JRNL AUTH 2 T.CANEQUE,L.TEPSHI,A.MARIANI,R.P.ST ONGE,G.GIAEVER,C.NISLOW, JRNL AUTH 3 E.CHARAFE-JAUFFRET,R.RODRIGUEZ,M.ZEGHOUF,J.CHERFILS JRNL TITL PH-DOMAIN-BINDING INHIBITORS OF NUCLEOTIDE EXCHANGE FACTOR JRNL TITL 2 BRAG2 DISRUPT ARF GTPASE SIGNALING. JRNL REF NAT.CHEM.BIOL. V. 15 358 2019 JRNL REFN ESSN 1552-4469 JRNL PMID 30742123 JRNL DOI 10.1038/S41589-019-0228-3 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 63.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 64.6 REMARK 3 NUMBER OF REFLECTIONS : 21952 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1093 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 63.3499 - 5.0023 1.00 4245 258 0.1999 0.2576 REMARK 3 2 5.0023 - 3.9706 1.00 4083 207 0.1815 0.2459 REMARK 3 3 3.9706 - 3.4688 1.00 4019 194 0.2276 0.2912 REMARK 3 4 3.4688 - 3.1516 0.99 3981 202 0.2645 0.3614 REMARK 3 5 3.1516 - 2.9257 0.61 2448 115 0.2968 0.3440 REMARK 3 6 2.9257 - 2.7532 0.31 1213 66 0.2921 0.2966 REMARK 3 7 2.7532 - 2.6153 0.17 661 36 0.3283 0.3332 REMARK 3 8 2.6153 - 2.5015 0.05 209 15 0.3022 0.3747 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.530 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 70.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5788 REMARK 3 ANGLE : 1.136 7769 REMARK 3 CHIRALITY : 0.055 841 REMARK 3 PLANARITY : 0.006 1013 REMARK 3 DIHEDRAL : 22.706 3583 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FNE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1200007195. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9801 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21954 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 65.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.18000 REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5NLY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 20000, 0.1 M TRIS PH 8.5, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.95600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 109.41150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.08050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 109.41150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.95600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.08050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 359 REMARK 465 SER A 360 REMARK 465 TYR A 361 REMARK 465 TYR A 362 REMARK 465 HIS A 363 REMARK 465 HIS A 364 REMARK 465 HIS A 365 REMARK 465 HIS A 366 REMARK 465 HIS A 367 REMARK 465 HIS A 368 REMARK 465 ASP A 369 REMARK 465 TYR A 370 REMARK 465 ASP A 371 REMARK 465 ILE A 372 REMARK 465 PRO A 373 REMARK 465 THR A 374 REMARK 465 THR A 375 REMARK 465 GLU A 376 REMARK 465 ASN A 377 REMARK 465 LEU A 378 REMARK 465 TYR A 379 REMARK 465 PHE A 380 REMARK 465 GLN A 381 REMARK 465 GLY A 382 REMARK 465 ALA A 383 REMARK 465 MET A 384 REMARK 465 GLY A 385 REMARK 465 SER A 386 REMARK 465 GLU A 387 REMARK 465 PHE A 388 REMARK 465 MET A 389 REMARK 465 SER A 390 REMARK 465 TRP A 391 REMARK 465 ASP A 392 REMARK 465 SER A 393 REMARK 465 PRO A 394 REMARK 465 ALA A 395 REMARK 465 PHE A 396 REMARK 465 PRO A 612 REMARK 465 ILE A 613 REMARK 465 GLY A 614 REMARK 465 SER A 615 REMARK 465 LEU A 616 REMARK 465 HIS A 617 REMARK 465 PRO A 618 REMARK 465 GLY A 619 REMARK 465 LEU A 620 REMARK 465 PRO A 710 REMARK 465 GLY A 711 REMARK 465 LYS A 758 REMARK 465 GLY A 759 REMARK 465 VAL A 760 REMARK 465 VAL A 761 REMARK 465 ARG A 762 REMARK 465 PRO A 763 REMARK 465 MET B 359 REMARK 465 SER B 360 REMARK 465 TYR B 361 REMARK 465 TYR B 362 REMARK 465 HIS B 363 REMARK 465 HIS B 364 REMARK 465 HIS B 365 REMARK 465 HIS B 366 REMARK 465 HIS B 367 REMARK 465 HIS B 368 REMARK 465 ASP B 369 REMARK 465 TYR B 370 REMARK 465 ASP B 371 REMARK 465 ILE B 372 REMARK 465 PRO B 373 REMARK 465 THR B 374 REMARK 465 THR B 375 REMARK 465 GLU B 376 REMARK 465 ASN B 377 REMARK 465 LEU B 378 REMARK 465 TYR B 379 REMARK 465 PHE B 380 REMARK 465 GLN B 381 REMARK 465 GLY B 382 REMARK 465 ALA B 383 REMARK 465 MET B 384 REMARK 465 GLY B 385 REMARK 465 SER B 386 REMARK 465 GLU B 387 REMARK 465 PHE B 388 REMARK 465 MET B 389 REMARK 465 SER B 390 REMARK 465 TRP B 391 REMARK 465 ASP B 392 REMARK 465 SER B 393 REMARK 465 PRO B 394 REMARK 465 ALA B 395 REMARK 465 PHE B 396 REMARK 465 SER B 397 REMARK 465 LYS B 610 REMARK 465 LYS B 611 REMARK 465 PRO B 612 REMARK 465 ILE B 613 REMARK 465 GLY B 614 REMARK 465 SER B 615 REMARK 465 LEU B 616 REMARK 465 HIS B 617 REMARK 465 PRO B 618 REMARK 465 GLY B 619 REMARK 465 LEU B 620 REMARK 465 GLY B 621 REMARK 465 CYS B 622 REMARK 465 LYS B 673 REMARK 465 ASN B 674 REMARK 465 SER B 675 REMARK 465 PRO B 710 REMARK 465 GLY B 711 REMARK 465 ALA B 712 REMARK 465 GLU B 751 REMARK 465 SER B 752 REMARK 465 GLU B 753 REMARK 465 LEU B 754 REMARK 465 GLU B 755 REMARK 465 LYS B 756 REMARK 465 GLN B 757 REMARK 465 LYS B 758 REMARK 465 GLY B 759 REMARK 465 VAL B 760 REMARK 465 VAL B 761 REMARK 465 ARG B 762 REMARK 465 PRO B 763 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 550 CG CD CE NZ REMARK 470 ASP A 713 CG OD1 OD2 REMARK 470 LYS B 403 CG CD CE NZ REMARK 470 ASP B 559 CG OD1 OD2 REMARK 470 LYS B 667 CG CD CE NZ REMARK 470 LYS B 672 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 622 CA - CB - SG ANGL. DEV. = 6.8 DEGREES REMARK 500 GLU B 552 C - N - CA ANGL. DEV. = 15.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 426 -4.20 -54.07 REMARK 500 GLN A 490 -3.10 -54.10 REMARK 500 GLN A 496 139.32 177.33 REMARK 500 PRO A 551 -38.60 -39.90 REMARK 500 ASP A 595 -168.68 -127.20 REMARK 500 LYS A 610 133.17 -176.11 REMARK 500 VAL A 623 -65.92 65.12 REMARK 500 LEU A 624 -32.24 72.53 REMARK 500 SER A 625 42.47 -91.81 REMARK 500 ASP A 661 10.47 -140.01 REMARK 500 LYS A 672 -168.85 -167.63 REMARK 500 ILE A 750 45.34 -79.78 REMARK 500 ASP B 432 46.85 -75.04 REMARK 500 THR B 479 -34.24 68.69 REMARK 500 GLU B 481 -88.88 -67.22 REMARK 500 LEU B 482 -44.27 -169.20 REMARK 500 TYR B 545 66.88 -117.22 REMARK 500 GLU B 552 -44.32 126.50 REMARK 500 LYS B 554 -10.58 -145.20 REMARK 500 LYS B 556 74.00 -16.63 REMARK 500 LEU B 557 -64.53 61.33 REMARK 500 LEU B 564 30.03 82.53 REMARK 500 ARG B 565 -90.85 -80.22 REMARK 500 VAL B 567 -41.84 -133.24 REMARK 500 PRO B 574 110.07 -31.40 REMARK 500 HIS B 652 49.67 73.12 REMARK 500 THR B 666 -164.02 -126.80 REMARK 500 ARG B 681 -62.83 -127.28 REMARK 500 ASN B 701 59.03 -111.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 914 DISTANCE = 6.17 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DY5 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2PE A 802 DBREF 6FNE A 390 763 UNP Q6DN90 IQEC1_HUMAN 512 885 DBREF 6FNE B 390 763 UNP Q6DN90 IQEC1_HUMAN 512 885 SEQADV 6FNE MET A 359 UNP Q6DN90 INITIATING METHIONINE SEQADV 6FNE SER A 360 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR A 361 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR A 362 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS A 363 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS A 364 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS A 365 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS A 366 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS A 367 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS A 368 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ASP A 369 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR A 370 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ASP A 371 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ILE A 372 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE PRO A 373 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE THR A 374 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE THR A 375 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLU A 376 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ASN A 377 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE LEU A 378 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR A 379 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE PHE A 380 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLN A 381 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLY A 382 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ALA A 383 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE MET A 384 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLY A 385 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE SER A 386 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLU A 387 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE PHE A 388 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE MET A 389 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE MET B 359 UNP Q6DN90 INITIATING METHIONINE SEQADV 6FNE SER B 360 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR B 361 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR B 362 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS B 363 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS B 364 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS B 365 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS B 366 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS B 367 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE HIS B 368 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ASP B 369 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR B 370 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ASP B 371 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ILE B 372 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE PRO B 373 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE THR B 374 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE THR B 375 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLU B 376 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ASN B 377 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE LEU B 378 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE TYR B 379 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE PHE B 380 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLN B 381 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLY B 382 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE ALA B 383 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE MET B 384 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLY B 385 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE SER B 386 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE GLU B 387 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE PHE B 388 UNP Q6DN90 EXPRESSION TAG SEQADV 6FNE MET B 389 UNP Q6DN90 EXPRESSION TAG SEQRES 1 A 405 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 405 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 A 405 GLY SER GLU PHE MET SER TRP ASP SER PRO ALA PHE SER SEQRES 4 A 405 ASN ASP VAL ILE ARG LYS ARG HIS TYR ARG ILE GLY LEU SEQRES 5 A 405 ASN LEU PHE ASN LYS LYS PRO GLU LYS GLY VAL GLN TYR SEQRES 6 A 405 LEU ILE GLU ARG GLY PHE VAL PRO ASP THR PRO VAL GLY SEQRES 7 A 405 VAL ALA HIS PHE LEU LEU GLN ARG LYS GLY LEU SER ARG SEQRES 8 A 405 GLN MET ILE GLY GLU PHE LEU GLY ASN ARG GLN LYS GLN SEQRES 9 A 405 PHE ASN ARG ASP VAL LEU ASP CYS VAL VAL ASP GLU MET SEQRES 10 A 405 ASP PHE SER THR MET GLU LEU ASP GLU ALA LEU ARG LYS SEQRES 11 A 405 PHE GLN ALA HIS ILE ARG VAL GLN GLY GLU ALA GLN LYS SEQRES 12 A 405 VAL GLU ARG LEU ILE GLU ALA PHE SER GLN ARG TYR CYS SEQRES 13 A 405 ILE CYS ASN PRO GLY VAL VAL ARG GLN PHE ARG ASN PRO SEQRES 14 A 405 ASP THR ILE PHE ILE LEU ALA PHE ALA ILE ILE LEU LEU SEQRES 15 A 405 ASN THR ASP MET TYR SER PRO ASN VAL LYS PRO GLU ARG SEQRES 16 A 405 LYS MET LYS LEU GLU ASP PHE ILE LYS ASN LEU ARG GLY SEQRES 17 A 405 VAL ASP ASP GLY GLU ASP ILE PRO ARG GLU MET LEU MET SEQRES 18 A 405 GLY ILE TYR GLU ARG ILE ARG LYS ARG GLU LEU LYS THR SEQRES 19 A 405 ASN GLU ASP HIS VAL SER GLN VAL GLN LYS VAL GLU LYS SEQRES 20 A 405 LEU ILE VAL GLY LYS LYS PRO ILE GLY SER LEU HIS PRO SEQRES 21 A 405 GLY LEU GLY CYS VAL LEU SER LEU PRO HIS ARG ARG LEU SEQRES 22 A 405 VAL CYS TYR CYS ARG LEU PHE GLU VAL PRO ASP PRO ASN SEQRES 23 A 405 LYS PRO GLN LYS LEU GLY LEU HIS GLN ARG GLU ILE PHE SEQRES 24 A 405 LEU PHE ASN ASP LEU LEU VAL VAL THR LYS ILE PHE GLN SEQRES 25 A 405 LYS LYS LYS ASN SER VAL THR TYR SER PHE ARG GLN SER SEQRES 26 A 405 PHE SER LEU TYR GLY MET GLN VAL LEU LEU PHE GLU ASN SEQRES 27 A 405 GLN TYR TYR PRO ASN GLY ILE ARG LEU THR SER SER VAL SEQRES 28 A 405 PRO GLY ALA ASP ILE LYS VAL LEU ILE ASN PHE ASN ALA SEQRES 29 A 405 PRO ASN PRO GLN ASP ARG LYS LYS PHE THR ASP ASP LEU SEQRES 30 A 405 ARG GLU SER ILE ALA GLU VAL GLN GLU MET GLU LYS HIS SEQRES 31 A 405 ARG ILE GLU SER GLU LEU GLU LYS GLN LYS GLY VAL VAL SEQRES 32 A 405 ARG PRO SEQRES 1 B 405 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 B 405 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 B 405 GLY SER GLU PHE MET SER TRP ASP SER PRO ALA PHE SER SEQRES 4 B 405 ASN ASP VAL ILE ARG LYS ARG HIS TYR ARG ILE GLY LEU SEQRES 5 B 405 ASN LEU PHE ASN LYS LYS PRO GLU LYS GLY VAL GLN TYR SEQRES 6 B 405 LEU ILE GLU ARG GLY PHE VAL PRO ASP THR PRO VAL GLY SEQRES 7 B 405 VAL ALA HIS PHE LEU LEU GLN ARG LYS GLY LEU SER ARG SEQRES 8 B 405 GLN MET ILE GLY GLU PHE LEU GLY ASN ARG GLN LYS GLN SEQRES 9 B 405 PHE ASN ARG ASP VAL LEU ASP CYS VAL VAL ASP GLU MET SEQRES 10 B 405 ASP PHE SER THR MET GLU LEU ASP GLU ALA LEU ARG LYS SEQRES 11 B 405 PHE GLN ALA HIS ILE ARG VAL GLN GLY GLU ALA GLN LYS SEQRES 12 B 405 VAL GLU ARG LEU ILE GLU ALA PHE SER GLN ARG TYR CYS SEQRES 13 B 405 ILE CYS ASN PRO GLY VAL VAL ARG GLN PHE ARG ASN PRO SEQRES 14 B 405 ASP THR ILE PHE ILE LEU ALA PHE ALA ILE ILE LEU LEU SEQRES 15 B 405 ASN THR ASP MET TYR SER PRO ASN VAL LYS PRO GLU ARG SEQRES 16 B 405 LYS MET LYS LEU GLU ASP PHE ILE LYS ASN LEU ARG GLY SEQRES 17 B 405 VAL ASP ASP GLY GLU ASP ILE PRO ARG GLU MET LEU MET SEQRES 18 B 405 GLY ILE TYR GLU ARG ILE ARG LYS ARG GLU LEU LYS THR SEQRES 19 B 405 ASN GLU ASP HIS VAL SER GLN VAL GLN LYS VAL GLU LYS SEQRES 20 B 405 LEU ILE VAL GLY LYS LYS PRO ILE GLY SER LEU HIS PRO SEQRES 21 B 405 GLY LEU GLY CYS VAL LEU SER LEU PRO HIS ARG ARG LEU SEQRES 22 B 405 VAL CYS TYR CYS ARG LEU PHE GLU VAL PRO ASP PRO ASN SEQRES 23 B 405 LYS PRO GLN LYS LEU GLY LEU HIS GLN ARG GLU ILE PHE SEQRES 24 B 405 LEU PHE ASN ASP LEU LEU VAL VAL THR LYS ILE PHE GLN SEQRES 25 B 405 LYS LYS LYS ASN SER VAL THR TYR SER PHE ARG GLN SER SEQRES 26 B 405 PHE SER LEU TYR GLY MET GLN VAL LEU LEU PHE GLU ASN SEQRES 27 B 405 GLN TYR TYR PRO ASN GLY ILE ARG LEU THR SER SER VAL SEQRES 28 B 405 PRO GLY ALA ASP ILE LYS VAL LEU ILE ASN PHE ASN ALA SEQRES 29 B 405 PRO ASN PRO GLN ASP ARG LYS LYS PHE THR ASP ASP LEU SEQRES 30 B 405 ARG GLU SER ILE ALA GLU VAL GLN GLU MET GLU LYS HIS SEQRES 31 B 405 ARG ILE GLU SER GLU LEU GLU LYS GLN LYS GLY VAL VAL SEQRES 32 B 405 ARG PRO HET DY5 A 801 19 HET 2PE A 802 28 HETNAM DY5 (2~{S})-6-METHYL-5-NITRO-2-(TRIFLUOROMETHYL)-2,3- HETNAM 2 DY5 DIHYDROCHROMEN-4-ONE HETNAM 2PE NONAETHYLENE GLYCOL FORMUL 3 DY5 C11 H8 F3 N O4 FORMUL 4 2PE C18 H38 O10 FORMUL 5 HOH *18(H2 O) HELIX 1 AA1 ASP A 399 LYS A 416 1 18 HELIX 2 AA2 LYS A 416 GLU A 426 1 11 HELIX 3 AA3 THR A 433 ARG A 444 1 12 HELIX 4 AA4 SER A 448 GLY A 457 1 10 HELIX 5 AA5 LYS A 461 GLU A 474 1 14 HELIX 6 AA6 GLU A 481 GLN A 490 1 10 HELIX 7 AA7 GLU A 498 ASN A 517 1 20 HELIX 8 AA8 ASN A 517 GLN A 523 1 7 HELIX 9 AA9 ASP A 528 TYR A 545 1 18 HELIX 10 AB1 LYS A 550 LYS A 554 5 5 HELIX 11 AB2 LYS A 556 LEU A 564 1 9 HELIX 12 AB3 PRO A 574 ARG A 588 1 15 HELIX 13 AB4 ASP A 595 LEU A 606 1 12 HELIX 14 AB5 ASN A 724 ILE A 750 1 27 HELIX 15 AB6 ASP B 399 LYS B 416 1 18 HELIX 16 AB7 LYS B 416 GLU B 426 1 11 HELIX 17 AB8 THR B 433 ARG B 444 1 12 HELIX 18 AB9 SER B 448 GLY B 457 1 10 HELIX 19 AC1 LYS B 461 GLU B 474 1 14 HELIX 20 AC2 LEU B 482 ILE B 493 1 12 HELIX 21 AC3 GLU B 498 ASN B 517 1 20 HELIX 22 AC4 ASN B 517 GLN B 523 1 7 HELIX 23 AC5 ASP B 528 TYR B 545 1 18 HELIX 24 AC6 LEU B 557 ASN B 563 1 7 HELIX 25 AC7 PRO B 574 ARG B 588 1 15 HELIX 26 AC8 ASP B 595 LEU B 606 1 12 HELIX 27 AC9 ASN B 724 HIS B 748 1 25 SHEET 1 AA1 8 ILE A 607 VAL A 608 0 SHEET 2 AA1 8 THR A 677 SER A 685 1 O PHE A 680 N VAL A 608 SHEET 3 AA1 8 LEU A 662 GLN A 670 -1 N VAL A 665 O GLN A 682 SHEET 4 AA1 8 GLN A 653 PHE A 659 -1 N PHE A 659 O LEU A 662 SHEET 5 AA1 8 LEU A 631 GLU A 639 -1 N CYS A 635 O ILE A 656 SHEET 6 AA1 8 LYS A 715 ASN A 721 -1 O ASN A 721 N PHE A 638 SHEET 7 AA1 8 GLY A 702 SER A 707 -1 N ILE A 703 O PHE A 720 SHEET 8 AA1 8 MET A 689 PHE A 694 -1 N LEU A 692 O ARG A 704 SHEET 1 AA2 8 ILE B 607 VAL B 608 0 SHEET 2 AA2 8 TYR B 678 SER B 685 1 O TYR B 678 N VAL B 608 SHEET 3 AA2 8 LEU B 662 ILE B 668 -1 N LEU B 663 O PHE B 684 SHEET 4 AA2 8 GLN B 653 PHE B 659 -1 N PHE B 659 O LEU B 662 SHEET 5 AA2 8 LEU B 631 GLU B 639 -1 N CYS B 633 O LEU B 658 SHEET 6 AA2 8 LYS B 715 ASN B 721 -1 O ASN B 721 N PHE B 638 SHEET 7 AA2 8 GLY B 702 SER B 707 -1 N ILE B 703 O PHE B 720 SHEET 8 AA2 8 MET B 689 PHE B 694 -1 N LEU B 692 O ARG B 704 CISPEP 1 GLY A 621 CYS A 622 0 -2.43 CISPEP 2 VAL B 549 LYS B 550 0 0.42 CISPEP 3 PRO B 551 GLU B 552 0 -1.34 CISPEP 4 VAL B 608 GLY B 609 0 -0.97 CISPEP 5 LEU B 626 PRO B 627 0 -3.72 SITE 1 AC1 4 HIS A 652 ARG A 654 LYS A 667 ARG A 681 SITE 1 AC2 6 LYS A 403 ARG A 407 LYS A 445 ARG A 630 SITE 2 AC2 6 VAL A 632 ASP A 734 CRYST1 65.912 66.161 218.823 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015172 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015115 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004570 0.00000